FDA Commissioner Marty Makary, whose agency convened a panel of experts earlier in the day to discuss the topic, told ...

US Food and Drug Administration Commissioner Marty Makary signaled Thursday that he is open to revising strict warning labels ...

The FDA is reevaluating longtime warnings on hormone replacement therapy products for menopausal women. Some advocates for change say the so-called “black box” that lists health risks is discouraging ...

Dr. Marty Makary, the agency’s commissioner, has said too many women avoid menopause treatments because the risks have been ...

The culture of academic medicine needs to change, FDA Commissioner Marty Makary, MD, MPH, said at an event sponsored by The ...

Just how many employees is Sarepta Therapeutics laying off? And why did the FDA reject Ultragenyx's rare disease drug over ...

US health authorities on Thursday began a reassessment of the risks surrounding Hormone Replacement Therapy (HRT), a treatment used by menopausal women around the world but long clouded by fear ...

Real change takes a long time, and when it happens, it must be recognized. The FDA and the NIH have announced their move away ...

Under President Joe Biden, the FDA rejected MDMA as a treatment for post-traumatic stress disorder, citing flawed data and ...